CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-10 | Cooke Shane Director | Sale | −255 | $54.20 | $14K | 4,745 |
| 2022-11-10 | Cooke Shane Director | Sale | −3,870 | $56.14 | $217K | 875 |
| 2022-11-10 | Cooke Shane Director | Sale | −875 | $56.85 | $50K | 0 |
| 2022-11-10 | Cooke Shane Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 10,000 | ||
| 2022-11-07 | COLLIER RICHARD T Director | Option exercise | +5,000 | $6.41 | $32K | 6,219 |
| 2022-11-07 | COLLIER RICHARD T Director | Sale | −1,486 | $54.74 | $81K | 4,733 |
| 2022-11-07 | COLLIER RICHARD T Director | Sale | −2,688 | $55.71 | $150K | 2,045 |
| 2022-11-07 | COLLIER RICHARD T Director | Sale | −826 | $56.89 | $47K | 1,219 |
| 2022-11-07 | COLLIER RICHARD T Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 10,000 | ||
| 2022-11-01 | Ekman Lars Director | Option exercise | +15,833 | $6.41 | $101K | 16,076 |
| 2022-11-01 | Ekman Lars Director | Sale | −9,143 | $62.01 | $567K | 6,933 |
| 2022-11-01 | Ekman Lars Director | Sale | −1,717 | $62.91 | $108K | 5,216 |
| 2022-11-01 | Ekman Lars Director | Sale | −3,312 | $64.26 | $213K | 1,904 |
| 2022-11-01 | Ekman Lars Director | Sale | −1,661 | $64.94 | $108K | 243 |
| 2022-11-01 | Ekman Lars Director | Option exercise · Stock Option (right to buy) | −15,833 | 31,668 | ||
| 2022-11-01 | Garren Hideki Chief Medical Officer | Option exercise | +4,000 | $24.90 | $100K | 4,000 |
| 2022-11-01 | Garren Hideki Chief Medical Officer | Sale | −3,489 | $61.82 | $216K | 511 |
| 2022-11-01 | Garren Hideki Chief Medical Officer | Sale | −511 | $62.41 | $32K | 0 |
| 2022-11-01 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,000 | 226,000 | ||
| 2022-10-27 | Malecek Michael J Chief Legal Officer | Option exercise | +20,000 | $10.27 | $205K | 20,000 |
Page 21 of 28 · 555 trades